Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Xiao Lin, Dan Xiong, Yi-Qun Peng, Zhi-Feng Sheng, Xi-Yu Wu, Xian-Ping Wu, Feng Wu, Ling-Qing Yuan & Er-Yuan Liao. (2015) Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives. Clinical Interventions in Aging 10, pages 1017-1033.
Read now
Read now
Ahmad Shuid Nazrun, Mohd Nizam Tzar, Sabarul Afian Mokhtar & Isa Naina Mohamed. (2014) A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Therapeutics and Clinical Risk Management 10, pages 937-948.
Read now
Read now
Karen Voigt, Stéphanie Taché, Matthias Hofer, Carsten Straßberger, Henna Riemenschneider, Peter Peschel, Joachim Kugler & Antje Bergmann. (2012) Health related quality of life in male patients with osteoporosis: results of a cross sectional study. The Aging Male 15:4, pages 220-226.
Read now
Read now
Santiago Palacios, Claus Christiansen, Rafael Sánchez Borrego, Marco Gambacciani, Payman Hadji, Morten Karsdal, Irene Lambrinoudaki, Stefano Lello, Barbara O’Beirne, Fatima Romao, Serge Rozenberg, John C. Stevenson & Zion Ben-Rafael. (2012) Recommendations on the management of fragility fracture risk in women younger than 70 years. Gynecological Endocrinology 28:10, pages 770-786.
Read now
Read now
Ingrid Bergström, Karin Bergström, Ann-Charlotte Grahn Kronhed, Susanne Karlsson & Jonas Brinck. (2011) Back extensor training increases muscle strength in postmenopausal women with osteoporosis, kyphosis and vertebral fractures. Advances in Physiotherapy 13:3, pages 110-117.
Read now
Read now
Ralph Hasserius, Acke Ohlin & Magnus K Karlsson. (2010) Vertebroplasty and kyphoplasty—evidence-based methods?. Acta Orthopaedica 81:5, pages 521-523.
Read now
Read now
Magnus K. Karlsson, Acke Ohlin & Ralph Hasserius. (2010) Could vertebroplasty and kyphoplasty be regarded as evidence-based treatment of osteoporotic vertebral fractures?. Acta Radiologica 51:8, pages 828-831.
Read now
Read now
Fredrik Borgström, Oskar Ström, Fernando Marin, Alexey Kutahov & Östen Ljunggren. (2010) Cost effectiveness of teriparatide and PTH(1-84) in the treatment of postmenopausal osteoporosis. Journal of Medical Economics 13:3, pages 381-392.
Read now
Read now
Articles from other publishers (68)
Chuwei Tian, Huanyi Zhu, Liu Shi, Xiangxu Chen, Tian Xie & Yunfeng Rui. (2023) Is There a “Black Friday” for Geriatric Hip Fracture Surgery?. Orthopaedic Surgery 15:5, pages 1304-1311.
Crossref
Crossref
Małgorzata Dziedzic, Mariola Janiszewska, Małgorzata Goździewska, Wioleta Kowalska & Jacek Roliński. (2022) Assessment of the Quality of Life of Women after Osteoporotic Vertebral Fracture with Consideration of Socio-Demographic Characteristics and Selected Factors Concerning the State of Health. International Journal of Environmental Research and Public Health 19:19, pages 12237.
Crossref
Crossref
Nithin Manohar Rayudu, Michael Dieckmeyer, Maximilian T. Löffler, Peter B. Noël, Jan S. Kirschke, Thomas Baum & Karupppasamy Subburaj. (2021) Predicting Vertebral Bone Strength Using Finite Element Analysis for Opportunistic Osteoporosis Screening in Routine Multidetector Computed Tomography Scans—A Feasibility Study. Frontiers in Endocrinology 11.
Crossref
Crossref
M. Ruiz-Adame & M. Correa. (2020) A systematic review of the indirect and social costs studies in fragility fractures. Osteoporosis International 31:7, pages 1205-1216.
Crossref
Crossref
Christian Labenz, Gerrit Toenges, Jörn M. Schattenberg, Michael Nagel, Yvonne Huber, Jens U. Marquardt, Peter R. Galle & Marcus-Alexander Wörns. (2019) Health-related quality of life in patients with compensated and decompensated liver cirrhosis. European Journal of Internal Medicine 70, pages 54-59.
Crossref
Crossref
Wen‐Yu Hsu, Cheng‐Li Lin & Chia‐Hung Kao. (2019) Association between opioid use disorder and fractures: a population‐based study. Addiction 114:11, pages 2008-2015.
Crossref
Crossref
L. Johansson, H. K. Svensson, J. Karlsson, L.-E. Olsson, D. Mellström, M. Lorentzon & D. Sundh. (2019) Decreased physical health-related quality of life—a persisting state for older women with clinical vertebral fracture. Osteoporosis International 30:10, pages 1961-1971.
Crossref
Crossref
Christian Labenz, Gerrit Toenges, Jörn M. Schattenberg, Michael Nagel, Martin F. Sprinzl, Marc Nguyen-Tat, Tim Zimmermann, Yvonne Huber, Jens U. Marquardt, Peter R. Galle & Marcus-Alexander Wörns. (2019) Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic Encephalopathy. Journal of Clinical Gastroenterology 53:7, pages e303-e307.
Crossref
Crossref
Lorenzo Ridola, Silvia Nardelli, Stefania Gioia & Oliviero Riggio. (2018) Quality of life in patients with minimal hepatic encephalopathy. World Journal of Gastroenterology 24:48, pages 5446-5453.
Crossref
Crossref
Tomoko Usui, Masaru Funagoshi, Kahori Seto, Kazuki Ide, Shiro Tanaka & Koji Kawakami. (2018) Persistence of and switches from teriparatide treatment among women and men with osteoporosis in the real world: a claims database analysis. Archives of Osteoporosis 13:1.
Crossref
Crossref
J. M. G. Curneen, M. Casey & E. Laird. (2017) The relationship between protein quantity, BMD and fractures in older adults. Irish Journal of Medical Science (1971 -) 187:1, pages 111-121.
Crossref
Crossref
Zoltán Vokó, Katalin Gáspár, András Inotai, Csaba Horváth, Katalin Bors, Gábor Speer & Zoltán Kaló. (2017) Osteoporotic fractures may impair life as much as the complications of diabetes. Journal of Evaluation in Clinical Practice 23:6, pages 1375-1380.
Crossref
Crossref
Ott Laius, Heti Pisarev, Katre Maasalu, Sulev Kõks & Aare Märtson. (2017) Adherence to osteoporosis medicines in Estonia—a comprehensive 15-year retrospective prescriptions database study. Archives of Osteoporosis 12:1.
Crossref
Crossref
Ott Laius, Heti Pisarev, Katre Maasalu, Sulev Kõks & Aare Märtson. (2017) Trends in and relation between hip fracture incidence and osteoporosis medication utilization and prices in Estonia in 2004–2015. Archives of Osteoporosis 12:1.
Crossref
Crossref
A. Modi, S. Sen, J. D. Adachi, S. Adami, B. Cortet, A. L. Cooper, P. Geusens, D. Mellström, J. P. Weaver, J. P. van den Bergh, P. A. Keown & S. Sajjan. (2017) Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS). Osteoporosis International 28:10, pages 2867-2876.
Crossref
Crossref
Claire E. O’Hanlon, Anju Parthan, Morgan Kruse, Shannon Cartier, Bjorn Stollenwerk, Yawen Jiang, John P. Caloyeras, Daria B. Crittenden & Richard Barron. (2017) A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture. Clinical Therapeutics 39:7, pages 1276-1290.
Crossref
Crossref
Kunhi Kannan & Muhammed Musthaque. (2017) A SURVEY ON TREATMENT REGIMENS USED IN THE COMMUNITY AND A TEACHING HOSPITAL FOR OSTEOPOROSIS- A COMBINED STUDY IN NORTHERN KERALA. Journal of Evidence Based Medicine and Healthcare 4:26, pages 1557-1563.
Crossref
Crossref
Suzanne M. Dyer, Maria Crotty, Nicola Fairhall, Jay Magaziner, Lauren A. Beaupre, Ian D. Cameron & Catherine Sherrington. (2016) A critical review of the long-term disability outcomes following hip fracture. BMC Geriatrics 16:1.
Crossref
Crossref
Jean-Eric Tarride, Natasha Burke, William D. Leslie, Suzanne N. Morin, Jonathan D. Adachi, Alexandra Papaioannou, Louis Bessette, Jacques P. Brown, Louisa Pericleous, Sergei Muratov & Robert B. Hopkins. (2016) Loss of health related quality of life following low-trauma fractures in the elderly. BMC Geriatrics 16:1.
Crossref
Crossref
Sarah Davis, Marrissa Martyn-St James, Jean Sanderson, John Stevens, Edward Goka, Andrew Rawdin, Susi Sadler, Ruth Wong, Fiona Campbell, Matt Stevenson, Mark Strong, Peter Selby & Neil Gittoes. (2016) A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Health Technology Assessment 20:78, pages 1-406.
Crossref
Crossref
M. Jürisson, H. Pisarev, J. Kanis, F. Borgström, A. Svedbom, R. Kallikorm, M. Lember & A. Uusküla. (2016) Quality of life, resource use, and costs related to hip fracture in Estonia. Osteoporosis International 27:8, pages 2555-2566.
Crossref
Crossref
Tamara Vokes. (2016) Utility of Vertebral Fracture Recognition in Osteoporosis. Clinical Reviews in Bone and Mineral Metabolism 14:1, pages 4-13.
Crossref
Crossref
Ott Laius, Katre Maasalu, Sulev Kõks & Aare Märtson. (2016) Use of drugs against osteoporosis in the Baltic countries during 2010–2014. Medicina 52:5, pages 315-320.
Crossref
Crossref
Anne-Luise Thorsteinsson, Peter Vestergaard & Pia Eiken. (2015) Compliance and persistence with treatment with parathyroid hormone for osteoporosis. A Danish national register-based cohort study. Archives of Osteoporosis 10:1.
Crossref
Crossref
A. Marques, Ó. Lourenço & J. A. P. da Silva. (2015) The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality. Osteoporosis International 26:11, pages 2623-2630.
Crossref
Crossref
Susanne Löfgren, Clas Rehnberg, Gunnar Ljunggren & Mats Brommels. (2014) Coordination pays off: a comparison of two models for organizing hip fracture care, outcomes and costs. The International Journal of Health Planning and Management 30:4, pages 426-438.
Crossref
Crossref
Swastik Agrawal, Sridharan Umapathy & Radha K. Dhiman. (2015) Minimal Hepatic Encephalopathy Impairs Quality of Life. Journal of Clinical and Experimental Hepatology 5, pages S42-S48.
Crossref
Crossref
Yolanda González, Antoni Sicras, Ricardo Larraínzar, Francesc Sorio, Laura Canals, Luis Lizán & Emilio Calvo. (2014) Estimación de los costes sanitarios relacionados con las fracturas osteoporóticas en pacientes posmenopáusicas en España. PharmacoEconomics Spanish Research Articles 12:1, pages 1-9.
Crossref
Crossref
O. Ström, E. Landfeldt & G. Garellick. (2014) Residual effect after oral bisphosphonate treatment and healthy adherer effects—the Swedish adherence register analysis (SARA). Osteoporosis International 26:1, pages 315-325.
Crossref
Crossref
John A. Kanis & Mickaël Hiligsmann. (2014) The application of health technology assessment in osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism 28:6, pages 895-910.
Crossref
Crossref
C.E. de Putter, R.W. Selles, J.A. Haagsma, S. Polinder, M.J.M. Panneman, S.E.R. Hovius, A. Burdorf & E.F. van Beeck. (2014) Health-related quality of life after upper extremity injuries and predictors for suboptimal outcome. Injury 45:11, pages 1752-1758.
Crossref
Crossref
Eric Swart, Eric C. Makhni, William Macaulay, Melvin P. Rosenwasser & Kevin J. Bozic. (2014) Cost-Effectiveness Analysis of Fixation Options for Intertrochanteric Hip Fractures. Journal of Bone and Joint Surgery 96:19, pages 1612-1620.
Crossref
Crossref
B. Qu, Y. Ma, M. Yan, H.-H. Wu, L. Fan, D.-F. Liao, X.-M. Pan & Z. Hong. (2014) The economic burden of fracture patients with osteoporosis in western China. Osteoporosis International 25:7, pages 1853-1860.
Crossref
Crossref
Yeshi Mikyas, Irene Agodoa & Nicole Yurgin. (2014) A Systematic Review of Osteoporosis Medication Adherence and Osteoporosis-Related Fracture Costs in Men. Applied Health Economics and Health Policy 12:3, pages 267-277.
Crossref
Crossref
A. Parthan, M. Kruse, I. Agodoa, S. Silverman & E. Orwoll. (2014) Denosumab: A cost-effective alternative for older men with osteoporosis from a Swedish payer perspective. Bone 59, pages 105-113.
Crossref
Crossref
Stefan Arver, Ba Luong, Anina Fraschke, Ola Ghatnekar, Sanja Stanisic, Dmitry Gultyev & Elvira Müller. (2014) Is Testosterone Replacement Therapy in Males with Hypogonadism Cost‐Effective? An Analysis in Sweden. The Journal of Sexual Medicine 11:1, pages 262-272.
Crossref
Crossref
K. Kim, A. Svedbom, X. Luo, S. Sutradhar & J. A. Kanis. (2013) Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm. Osteoporosis International 25:1, pages 325-337.
Crossref
Crossref
D. A. Eekman, M. M. ter Wee, V. M. H. Coupé, S. Erisek-Demirtas, M. H. Kramer & W. F. Lems. (2013) Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluation. Osteoporosis International 25:1, pages 195-204.
Crossref
Crossref
Svanhild Waterloo, Anne J Søgaard, Luai A Ahmed, Elin Damsgård, Bente Morseth & Nina Emaus. (2013) Vertebral fractures and self-perceived health in elderly women and men in a population-based cross-sectional study: the Tromsø Study 2007–08. BMC Geriatrics 13:1.
Crossref
Crossref
Chang-Bi Wang, Chien-Fu Jeff Lin, Wen-Miin Liang, Chi-Fung Cheng, Yu-Jun Chang, Hsi-Chin Wu, Trong-Neng Wu & Tsai-Hsueh Leu. (2013) Excess mortality after hip fracture among the elderly in Taiwan: A nationwide population-based cohort study. Bone 56:1, pages 147-153.
Crossref
Crossref
W. D. Leslie, L. M. Lix, G. S. Finlayson, C. J. Metge, S. N. Morin & S. R. Majumdar. (2013) Direct healthcare costs for 5 years post-fracture in Canada. Osteoporosis International 24:5, pages 1697-1705.
Crossref
Crossref
O. Ström, B. Jönsson & J. A. Kanis. (2012) Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis. Osteoporosis International 24:4, pages 1491-1502.
Crossref
Crossref
F. Borgström, I. Lekander, M. Ivergård, O. Ström, A. Svedbom, V. Alekna, M. L. Bianchi, P. Clark, M. D. Curiel, H. P. Dimai, M. Jürisson, R. Kallikorm, O. Lesnyak, E. McCloskey, E. Nassonov, K. M. Sanders, S. Silverman, M. Tamulaitiene, T. Thomas, A. N. A. Tosteson, B. Jönsson & J. A. Kanis. (2013) The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture. Osteoporosis International 24:3, pages 811-823.
Crossref
Crossref
R. B. Hopkins, J. E. Tarride, W. D. Leslie, C. Metge, L. M. Lix, S. Morin, G. Finlayson, M. Azimaee, E. Pullenayegum, R. Goeree, J. D. Adachi, A. Papaioannou & L. Thabane. (2012) Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis. Osteoporosis International 24:2, pages 581-593.
Crossref
Crossref
Kazem Alzahouri, Stéphane Bahrami, Isabelle Durand-Zaleski, Francis Guillemin & Christian Roux. (2013) Cost-effectiveness of osteoporosis treatments in postmenopausal women using FRAX™ thresholds for decision. Joint Bone Spine 80:1, pages 64-69.
Crossref
Crossref
F. J. B. Lötters, I. Lenoir-Wijnkoop, P. Fardellone, R. Rizzoli, E. Rocher & M. J. Poley. (2012) Dairy foods and osteoporosis: an example of assessing the health-economic impact of food products. Osteoporosis International 24:1, pages 139-150.
Crossref
Crossref
Kim Brixen, Søren Overgaard, Jeppe Gram, Jesper Ryg, Mette Rothmann, Claire Gudex & Jan Sørensen. 2013. European Instructional Lectures. European Instructional Lectures
3
13
.
Kazem Alzahouri, Stéphane Bahrami, Isabelle Durand-Zaleski, Francis Guillemin & Christian Roux. (2012) Utilisation du FRAX™ dans l’analyse coût–efficacité des traitements antiostéoporotiques chez les femmes ménopausées. Revue du Rhumatisme 79:6, pages 557-563.
Crossref
Crossref
Kristin Siggeirsdottir, Thor Aspelund, Brynjolfur Y. Jonsson, Brynjolfur Mogensen, Lenore J. Launer, Tamara B. Harris, Gunnar Sigurdsson & Vilmundur Gudnason. (2012) Effect of vertebral fractures on function, quality of life and hospitalisation the AGES-Reykjavik study. Age and Ageing 41:3, pages 351-357.
Crossref
Crossref
C. M. McDonough, M. R. Grove, A. D. Elledge & A. N. A. Tosteson. (2011) Predicting EQ-5D-US and SF-6D societal health state values from the Osteoporosis Assessment Questionnaire. Osteoporosis International 23:2, pages 723-732.
Crossref
Crossref
Péter Lakatos, Ádám Balogh, Edward Czerwinski, Hans P. Dimai, Didier Hans, Gerold Holzer, Roman S. Lorenc, Vladimir Palicka, Barbara Obermayer-Pietsch, Jan Stepan, István Takács & Heinrich Resch. (2011) New considerations on the management of osteoporosis in Central and Eastern Europe (CEE): summary of the “3rd Summit on Osteoporosis—CEE”, November 2009, Budapest, Hungary. Archives of Osteoporosis 6:1-2, pages 1-12.
Crossref
Crossref
C.J. Jansen, E.M. Abma, J.H. Hegeman, P. Nieboer, H.J. ten Duis & J.P.J. Slaets. (2012) Kwetsbaarheid als indicator voor herstel na een fractuur. Nederlands Tijdschrift voor Traumatologie 19:3, pages 51-57.
Crossref
Crossref
Eva Román, Joan Córdoba, Maria Torrens, Xavier Torras, Càndid Villanueva, Víctor Vargas, Carlos Guarner & Germán Soriano. (2011) Minimal Hepatic Encephalopathy Is Associated With Falls. American Journal of Gastroenterology 106:3, pages 476-482.
Crossref
Crossref
B. Jönsson, O. Ström, J. A. Eisman, A. Papaioannou, E. S. Siris, A. Tosteson & J. A. Kanis. (2010) Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. Osteoporosis International 22:3, pages 967-982.
Crossref
Crossref
F. Borgström, O. Ström, M. Kleman, E. McCloskey, H. Johansson, A. Odén & J. A. Kanis. (2010) Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective. Osteoporosis International 22:3, pages 955-965.
Crossref
Crossref
John A. Kanis, Eugene V. McCloskey, Bengt Jonsson, Alun Cooper, Oskar Ström & Fredrik Borgström. (2010) An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women. Archives of Osteoporosis 5:1-2, pages 19-48.
Crossref
Crossref
A. Duclos, S. Couray-Targe, M. Randrianasolo, S. Hedoux, C. M. Couris, C. Colin & A. M. Schott. (2009) Burden of hip fracture on inpatient care: a before and after population-based study. Osteoporosis International 21:9, pages 1493-1501.
Crossref
Crossref
O. Ström, F. Borgström, M. Kleman, E. McCloskey, A. Odén, H. Johansson & J.A. Kanis. (2010) FRAX® and its applications in health economics—Cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example. Bone 47:2, pages 430-437.
Crossref
Crossref
Anna Darelid, Claes Ohlsson, Robert Rudäng, Jenny M Kindblom, Dan Mellström & Mattias Lorentzon. (2010) Trabecular volumetric bone mineral density is associated with previous fracture during childhood and adolescence in males: The GOOD study. Journal of Bone and Mineral Research 25:3, pages 537-544.
Crossref
Crossref
F. Borgström, O. Ström, J. Coelho, H. Johansson, A. Oden, E. V. McCloskey & J. A. Kanis. (2009) The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®. Osteoporosis International 21:3, pages 495-505.
Crossref
Crossref
F. Borgström, O. Ström, J. Coelho, H. Johansson, A. Oden, E. McCloskey & J. A. Kanis. (2009) The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis. Osteoporosis International 21:2, pages 339-349.
Crossref
Crossref
Gladius Lewis, Mark R. Towler, Daniel Boyd, Matthew J. German, Anthony W. Wren, Owen M. Clarkin & Andrew Yates. (2009) Evaluation of two novel aluminum-free, zinc-based glass polyalkenoate cements as alternatives to PMMA bone cement for use in vertebroplasty and balloon kyphoplasty. Journal of Materials Science: Materials in Medicine 21:1, pages 59-66.
Crossref
Crossref
Carsten Strassberger, Leonore Unger, Andreas T. Weber, Alexander Defer & Felix A. Bonnaire. (2009) Management of osteoporosis-related bone fractures: an integrated concept of care. Archives of Orthopaedic and Trauma Surgery 130:1, pages 103-109.
Crossref
Crossref
T. Peasgood, K. Herrmann, J. A. Kanis & J. E. Brazier. (2009) An updated systematic review of Health State Utility Values for osteoporosis related conditions. Osteoporosis International 20:6, pages 853-868.
Crossref
Crossref
Peter A Cole, Theodore MiclauIIIIII, Thuan V Ly, Julie A Switzer, Mengnai Li, Robert A Morgan & Mohit Bhandari. (2008) Whatʼs New in Orthopaedic Trauma. The Journal of Bone and Joint Surgery-American Volume 90:12, pages 2804-2822.
Crossref
Crossref
Fredrik Borgström & John A. Kanis. (2008) Health economics of osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism 22:5, pages 885-900.
Crossref
Crossref
Vaia Karapanou. (2011) Pain and Suffering Damages Based on QALYs: Circumventing Victims' (and Juries') Hedonic Misperceptions. SSRN Electronic Journal.
Crossref
Crossref
Vaia Karapanou & Louis T. Visscher. (2010) Quality Adjusted Life Years as a Way Out of the Impasse between Prevention Theory and Insurance Theory. SSRN Electronic Journal.
Crossref
Crossref